{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T03:16:41Z","timestamp":1783480601849,"version":"3.55.0"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T00:00:00Z","timestamp":1769817600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer, Inc.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Biannual mass azithromycin distribution to children aged 1\u201359 months reduces all-cause child mortality but selects for antimicrobial resistance (AMR). The World Health Organization (WHO) recommends ongoing surveillance of AMR in the context of azithromycin distribution. We evaluated the impact of twice-yearly distribution of azithromycin compared to placebo on AMR in the gut of children in Burkina Faso.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The Community Health with Azithromycin Trial (CHAT) was a 1:1 cluster randomized placebo-controlled trial in Nouna District, Burkina Faso, from 2019 to 2023. Communities were randomized in a 1:1 fashion to twice-yearly azithromycin (20 mg\/kg) or matching placebo. At 36 months, rectal swabs were collected from a random sample of 15 children per community in 48 communities participating in the trial and assessed for AMR genetic resistance determinants using next-generation DNA sequencing (DNA-seq). We assessed the fold-change in macrolide and nonmacrolide resistance determinants between treatment groups after 36 months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 483 samples from 41 communities were analyzed at 36 months. There was no evidence of a difference in macrolide resistance determinants in the azithromycin group compared to the placebo group (fold-change, 1.21; 95% confidence interval [CI], .96\u20131.52; P = .62). There was no evidence of a difference in nonmacrolide resistance genes; for example, beta-lactam resistance was similar between treatment groups (fold-change, 1.05; 95% CI, .79\u20131.40; P = .81).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In this setting in Burkina Faso, twice-yearly azithromycin distributions to children aged 1\u201359 months did not lead to statistically significant differences in macrolide or nonmacrolide genetic resistance determinants at 36 months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical Trial Registration<\/jats:title>\n                    <jats:p>ClinicalTrials.gov NCT03676764.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/cid\/ciag051","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T12:48:24Z","timestamp":1769690904000},"page":"946-953","source":"Crossref","is-referenced-by-count":1,"title":["Macrolide and Nonmacrolide Resistance After 36 Months of Mass Azithromycin Distribution in Burkina Faso: A Cluster Randomized Trial"],"prefix":"10.1093","volume":"82","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0763-399X","authenticated-orcid":false,"given":"Catherine E","family":"Oldenburg","sequence":"first","affiliation":[{"name":"Francis I Proctor Foundation, University of California , SanFrancisco, CA ,","place":["USA"]},{"name":"Department of Epidemiology & Biostatistics, University of California , SanFrancisco, CA ,","place":["USA"]},{"name":"Department of Ophthalmology, University of California , SanFrancisco, CA ,","place":["USA"]},{"name":"Institute for Global Health Sciences, University of California , SanFrancisco, CA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boubacar","family":"Coulibaly","sequence":"additional","affiliation":[{"name":"Centre de Recherche en Sant\u00e9 de Nouna , Nouna ,","place":["Burkina Faso"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Si\u00e9","sequence":"additional","affiliation":[{"name":"Francis I Proctor Foundation, University of California , SanFrancisco, CA ,","place":["USA"]},{"name":"Institute for Global Health Sciences, University of California , SanFrancisco, CA ,","place":["USA"]},{"name":"Centre de Recherche en Sant\u00e9 de Nouna , Nouna ,","place":["Burkina Faso"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamadou","family":"Ouattara","sequence":"additional","affiliation":[{"name":"Centre de Recherche en Sant\u00e9 de Nouna , Nouna ,","place":["Burkina Faso"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamadou","family":"Bountogo","sequence":"additional","affiliation":[{"name":"Centre de Recherche en Sant\u00e9 de Nouna , Nouna ,","place":["Burkina Faso"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Compaor\u00e9","sequence":"additional","affiliation":[{"name":"Centre de Recherche en Sant\u00e9 de Nouna , Nouna ,","place":["Burkina Faso"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dramane","family":"Kiemde","sequence":"additional","affiliation":[{"name":"Centre de Recherche en Sant\u00e9 de Nouna , Nouna ,","place":["Burkina Faso"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adama","family":"Compaor\u00e9","sequence":"additional","affiliation":[{"name":"Centre de Recherche en Sant\u00e9 de Nouna , Nouna ,","place":["Burkina Faso"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Zonou","sequence":"additional","affiliation":[{"name":"Centre de Recherche en Sant\u00e9 de Nouna , Nouna ,","place":["Burkina Faso"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6450-488X","authenticated-orcid":false,"given":"Armin","family":"Hinterwirth","sequence":"additional","affiliation":[{"name":"Francis I Proctor Foundation, University of California , SanFrancisco, CA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Zhong","sequence":"additional","affiliation":[{"name":"Francis I Proctor Foundation, University of California , SanFrancisco, CA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindi","family":"Chen","sequence":"additional","affiliation":[{"name":"Francis I Proctor Foundation, University of California , SanFrancisco, CA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YuHeng","family":"Liu","sequence":"additional","affiliation":[{"name":"Francis I Proctor Foundation, University of California , SanFrancisco, CA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danny","family":"Yu","sequence":"additional","affiliation":[{"name":"Francis I Proctor Foundation, University of California , SanFrancisco, CA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Abraham","sequence":"additional","affiliation":[{"name":"Francis I Proctor Foundation, University of California , SanFrancisco, CA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elodie","family":"Lebas","sequence":"additional","affiliation":[{"name":"Francis I Proctor Foundation, University of California , SanFrancisco, CA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiyu","family":"Hu","sequence":"additional","affiliation":[{"name":"Francis I Proctor Foundation, University of California , SanFrancisco, CA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milan","family":"Hilde-Jones","sequence":"additional","affiliation":[{"name":"Francis I Proctor Foundation, University of California , SanFrancisco, CA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin F","family":"Arnold","sequence":"additional","affiliation":[{"name":"Francis I Proctor Foundation, University of California , SanFrancisco, CA ,","place":["USA"]},{"name":"Department of Ophthalmology, University of California , SanFrancisco, CA ,","place":["USA"]},{"name":"Institute for Global Health Sciences, University of California , SanFrancisco, CA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2733-8370","authenticated-orcid":false,"given":"Thuy","family":"Doan","sequence":"additional","affiliation":[{"name":"Francis I Proctor Foundation, University of California , SanFrancisco, CA ,","place":["USA"]},{"name":"Department of Ophthalmology, University of California , SanFrancisco, CA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M","family":"Lietman","sequence":"additional","affiliation":[{"name":"Francis I Proctor Foundation, University of California , SanFrancisco, CA ,","place":["USA"]},{"name":"Department of Epidemiology & Biostatistics, University of California , SanFrancisco, CA ,","place":["USA"]},{"name":"Department of Ophthalmology, University of California , SanFrancisco, CA ,","place":["USA"]},{"name":"Institute for Global Health Sciences, University of California , SanFrancisco, CA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,1,31]]},"reference":[{"key":"2026070722332117400_ciag051-B1","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1001\/jama.2023.27393","article-title":"Mass azithromycin distribution to prevent child mortality in Burkina Faso: the CHAT randomized clinical trial","volume":"331","author":"Oldenburg","year":"2024","journal-title":"JAMA"},{"key":"2026070722332117400_ciag051-B2","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1056\/NEJMoa1715474","article-title":"Azithromycin to reduce childhood mortality in Sub-Saharan Africa","volume":"378","author":"Keenan","year":"2018","journal-title":"N Engl J Med"},{"key":"2026070722332117400_ciag051-B3","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa2312093","article-title":"Azithromycin to reduce mortality\u2014an adaptive cluster-randomized trial","volume":"391","author":"O\u2019Brien","year":"2024","journal-title":"N Engl J Med"},{"key":"2026070722332117400_ciag051-B4","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1016\/S1473-3099(18)30444-4","article-title":"Antimicrobial resistance following mass azithromycin distribution for trachoma: a systematic review","volume":"19","author":"O\u2019Brien","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"2026070722332117400_ciag051-B5","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1086\/655697","article-title":"The decline of pneumococcal resistance after cessation of mass antibiotic distributions for trachoma","volume":"51","author":"Haug","year":"2010","journal-title":"Clin Infect Dis"},{"key":"2026070722332117400_ciag051-B6","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12866-017-0982-x","article-title":"Short-term increase in prevalence of nasopharyngeal carriage of macrolide-resistant Staphylococcus aureus following mass drug administration with azithromycin for trachoma control","volume":"17","author":"Bojang","year":"2017","journal-title":"BMC Microbiol"},{"key":"2026070722332117400_ciag051-B7","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1093\/ije\/dyu062","article-title":"Increased carriage of macrolide-resistant fecal E. coli following mass distribution of azithromycin for trachoma control","volume":"43","author":"Seidman","year":"2014","journal-title":"Int J Epidemiol"},{"key":"2026070722332117400_ciag051-B8","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1093\/clinids\/24.3.356","article-title":"A prospective study of the impact of community-based azithromycin treatment of trachoma on carriage and resistance of Streptococcus pneumoniae","volume":"24","author":"Leach","year":"1997","journal-title":"Clin Infect Dis"},{"key":"2026070722332117400_ciag051-B9","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1056\/NEJMoa2002606","article-title":"Macrolide and nonmacrolide resistance with mass azithromycin distribution","volume":"383","author":"Doan","year":"2020","journal-title":"N Engl J Med"},{"key":"2026070722332117400_ciag051-B10","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1111\/tmi.13321","article-title":"Impact of the addition of azithromycin to antimalarials used for seasonal malaria chemoprevention on antimicrobial resistance of Streptococcus pneumoniae","volume":"24","author":"Hema-Ouangraoua","year":"2019","journal-title":"Trop Med Int Health"},{"key":"2026070722332117400_ciag051-B11","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1186\/s13063-019-3855-9","article-title":"A double-masked placebo-controlled trial of azithromycin to prevent child mortality in Burkina Faso, West Africa: Community Health with Azithromycin Trial (CHAT) study protocol","volume":"20","author":"Si\u00e9","year":"2019","journal-title":"Trials"},{"key":"2026070722332117400_ciag051-B12","doi-asserted-by":"crossref","first-page":"5284","DOI":"10.3402\/gha.v3i0.5284","article-title":"The health and demographic surveillance system (HDSS) in Nouna, Burkina Faso, 1993\u20132007","volume":"3","author":"Sie","year":"2010","journal-title":"Glob Health Action"},{"key":"2026070722332117400_ciag051-B13","doi-asserted-by":"crossref","first-page":"e1004386","DOI":"10.1371\/journal.pmed.1004386","article-title":"Prolonged mass azithromycin distributions and macrolide resistance determinants among preschool children in Niger: a sub-study of a cluster-randomized trial (MORDOR)","volume":"21","author":"Arzika","year":"2024","journal-title":"PLoS Med"},{"key":"2026070722332117400_ciag051-B14","doi-asserted-by":"crossref","first-page":"D574","DOI":"10.1093\/nar\/gkw1009","article-title":"MEGARes: an antimicrobial resistance database for high throughput sequencing","volume":"45","author":"Lakin","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"2026070722332117400_ciag051-B15","doi-asserted-by":"crossref","first-page":"D744","DOI":"10.1093\/nar\/gkac1047","article-title":"MEGARes and AMR++, v3.0: an updated comprehensive database of antimicrobial resistance determinants and an improved software pipeline for classification using high-throughput sequencing","volume":"51","author":"Bonin","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"2026070722332117400_ciag051-B16","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1093\/cid\/ciab471","article-title":"Indication for antibiotic prescription among children attending primary healthcare services in rural Burkina Faso","volume":"73","author":"Si\u00e9","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2026070722332117400_ciag051-B17","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"2026070722332117400_ciag051-B18","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMc1901535","article-title":"Macrolide resistance in MORDOR I\u2014a cluster-randomized trial in Niger","volume":"380","author":"Doan","year":"2019","journal-title":"N Engl J Med"},{"key":"2026070722332117400_ciag051-B19","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.4269\/ajtmh.18-0791","article-title":"Antibiotic prescription patterns among children younger than 5 years in Nouna District, Burkina Faso","volume":"100","author":"Si\u00e9","year":"2019","journal-title":"Am J Trop Med Hyg"},{"key":"2026070722332117400_ciag051-B20","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1080\/14787210.2016.1227702","article-title":"Non-prescription sale and dispensing of antibiotics in community pharmacies in Zambia","volume":"14","author":"Kalungia","year":"2016","journal-title":"Expert Rev Anti Infect Ther"},{"key":"2026070722332117400_ciag051-B21","doi-asserted-by":"crossref","first-page":"291","DOI":"10.4269\/ajtmh.23-0651","article-title":"Gut microbiome diversity and antimicrobial resistance after a single dose of oral azithromycin in children: a randomized placebo-controlled trial","volume":"110","author":"Doan","year":"2024","journal-title":"Am J Trop Med Hyg"},{"key":"2026070722332117400_ciag051-B22","doi-asserted-by":"crossref","first-page":"ofy289","DOI":"10.1093\/ofid\/ofy289","article-title":"Effect of commonly-used pediatric antibiotics on gut microbial diversity in preschool children in Burkina Faso: a randomized clinical trial","volume":"5","author":"Oldenburg","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"2026070722332117400_ciag051-B23","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1093\/cid\/cix141","article-title":"Gut microbial diversity in antibiotic-na\u00efve children after systemic antibiotic exposure: a randomized controlled trial","volume":"64","author":"Doan","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2026070722332117400_ciag051-B24","doi-asserted-by":"crossref","first-page":"107794","DOI":"10.1016\/j.ijid.2025.107794","article-title":"Effect of one prophylactic dose of azithromycin on Bifidobacterium infantis colonization in infants from the Mumta trial","volume":"153","author":"Pasha","year":"2025","journal-title":"Int J Infect Dis"},{"key":"2026070722332117400_ciag051-B25","doi-asserted-by":"crossref","first-page":"110626","DOI":"10.1016\/j.isci.2024.110626","article-title":"Effect of intrapartum azithromycin on gut microbiota development in early childhood: a post hoc analysis of a double-blind randomized trial","volume":"27","author":"Sanyang","year":"2024","journal-title":"iScience"},{"key":"2026070722332117400_ciag051-B26","doi-asserted-by":"crossref","first-page":"756318","DOI":"10.3389\/fpubh.2022.756318","article-title":"Biannual administrations of azithromycin and the gastrointestinal microbiome of Malawian children: a nested cohort study within a randomized controlled trial","volume":"10","author":"Chaima","year":"2022","journal-title":"Front Public Health"},{"key":"2026070722332117400_ciag051-B27","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13099-021-00478-6","article-title":"Impact of azithromycin mass drug administration on the antibiotic-resistant gut microbiome in children: a randomized, controlled trial","volume":"14","author":"Pickering","year":"2022","journal-title":"Gut Pathog"},{"key":"2026070722332117400_ciag051-B28","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/s41591-019-0533-0","article-title":"Gut microbiome alteration in MORDOR I: a community-randomized trial of mass azithromycin distribution","volume":"25","author":"Doan","year":"2019","journal-title":"Nat Med"},{"key":"2026070722332117400_ciag051-B29","doi-asserted-by":"crossref","first-page":"ofy182","DOI":"10.1093\/ofid\/ofy182","article-title":"Mass azithromycin distribution and community microbiome: a cluster-randomized trial","volume":"5","author":"Doan","year":"2018","journal-title":"Open Forum Infect Dis"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciag051\/66706421\/ciag051.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/82\/6\/946\/66706421\/ciag051.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/82\/6\/946\/66706421\/ciag051.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T02:34:16Z","timestamp":1783478056000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/82\/6\/946\/8454632"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,31]]},"references-count":29,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,1,31]]},"published-print":{"date-parts":[[2026,7,8]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciag051","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,6,15]]},"published":{"date-parts":[[2026,1,31]]}}}